Jeffrey R Bishop

Jeffrey R Bishop serves as Professor in Experimental and Clinical Pharmacology and Adjunct Associate Professor in Psychiatry & Behavioral Sciences at the University of Minnesota. His work contributes to multiple UN Sustainable Development Goals through pharmacogenomics research and precision medicine implementation.

Dr. Bishop's primary research interests focus on psychopharmacology, pharmacogenomics, pharmacogenetics, epigenetics, and proteomics, with particular emphasis on schizophrenia, antipsychotic treatments, and genotype-phenotype relationships. His fingerprint analysis shows strong connections to schizophrenia research (100%), antipsychotics (62%), genotype studies (59%), and pharmacogenetics (58%).

Recent publication trends demonstrate continued productivity with 170 research outputs including 123 articles and 37 review articles. His 2025 publications span schizophrenia neurobiology, pharmacogenomics implementation, and innovative applications of large language models to dietary supplement information retrieval, reflecting an interdisciplinary approach bridging psychiatry, pharmacology, and computational methods.

Dr. Bishop has led and collaborated on significant research projects including Toward Pharmacogenomics-Enabled Healthcare at Statewide Scale, Integrated, Individualized, Intelligent Prescribing (I3P) as Principal Investigator, and the Epigenetics of PTSD Treatment Response study. He also contributes to the Pharmacogenomics Global Research Network Implementation Working Group advancing international collaboration in pharmacogenetic implementation.

His research team collaborates across multiple institutions through projects like the Minnesota Precision Medicine Collaborative and a Community-based Approach toward Advancing Personalized Medicine in Underserved Populations, with particular focus on Hmong communities in Minnesota.